To investigate the indispensability of PIK3C3’s kinase activity in EBOV infection, we employed a selective PIK3C3 kinase inhibitor, VPS34-IN-1 [53], and assessed its efficacy against EBOVΔVP30-EGFP infection. This evidence concerns the gene PIK3C3 and infection.